Detection of Serum MicroRNA-92 in Patients with Epithelial Ovarian Carcinoma

郭凤军,邹颖刚,范丽梅,田静岩,崔满华

2015-01-01

Abstract:Objective The present study prospectively detected the status of miRNA-92 (miR-92)in the serum of EOC patients and healthy controls,and investigated the relationship between miR-92 and the clinical staging and grad-ing of EOC patients.Aim to provide theoretical basis for a new noninvasive screening and assessing prognosis method for EOC patients.Methods The relatively expression levels of miR-92 in serum samples from 50 EOC patients and 50 healthy controls were measured by using quantitative reverse transcription-polymerase chain reaction(qRT-PCR).ROC curve was applied to evaluate the clinical diagnosis value.In addition,the associations between serum miR-92 concentra-tions and clinical characters were analysed to assesse the clinical prognosis value.Results As a maker of EOC,serum miR-92 is feasible with 0.803 the areas under the receiver operator characteristic curve.The serum concentration of miR-92 in EOC patients was significantly higher than that in healthy controls (P <0.05).The expression of miR-92 was correlated to progression of the clinical stages and regional lymph nodes (P <0.05),There was no significant asso-ciation between expression of miR-92 and age.Conclusion These findings imply that expression of miR-92 in EOC pa-tients was significantly higher than healthy controls and miR-92 may promote the initiation and progression of EOC. The detection of miR-92 in serum might become a novel non-invasive tumor biomarker in early detection and assessment of prognosis of EOC.